|
KMID : 1035620230110030126
|
|
Allergy Asthma & Respiratory Disease
2023 Volume.11 No. 3 p.126 ~ p.134
|
|
|
KAAACI Allergic Rhinitis Guidelines: Part 2. Update in nonpharmacotherapy
|
|
Park Sang-Chul
Chung Soo-Jie
Choi Jeong-Hee
Lee Yong-Ju
Yang Hyeon-Jong
Park Do-Yang
Kim Dong-Kyu
Lee Il-Hwan
Kim Soo-Whan
Kim Do-Hyun
Jun Young-Joon
Yang Song-I
Kim Min-Ji
Ryu Gwang-Hui
Kang Sung-Yoon
Lee Sang-Min
Kim Mi-Ae
Kim Hyun-Jung
Choi Gil-Soon
Lee Hyun-Jong
Kim Hyo-Bin
Kim Bong-Seong
|
|
|
Abstract
|
|
|
|
Allergic rhinitis is the most common chronic disease worldwide. Various upper airway symptoms lower quality of life, and due to the recurrent symptoms, multiple treatments are usually attempted rather than one definitive treatment. There are alternatives to medical (medication-based) and nonmedical treatments. A guideline is needed to understand allergic rhinitis and develop an appropriate treatment plan. We have developed guidelines for medical treatment based on previous reports. The current guidelines herein are associated with the “KAAACI Evidence-Based Guidelines for Allergic Rhinitis in Korea, Part 1: Update in pharmacotherapy” in which we aimed to provide evidence-based recommendations for the medical treatment of allergic rhinitis. Part 2 focuses on nonpharmacological management, including allergen-specific immunotherapy, subcutaneous or sublingual immunotherapy, nasal saline irrigation, environmental management strategies, companion animal management, and nasal turbinate surgery. The evidence to support the treatment efficacy, safety, and selection has been systematically reviewed. However, larger controlled studies are needed to elevate the level of evidence to select rational non-medical therapeutic options for patients with allergic rhinitis.
|
|
|
KEYWORD
|
|
|
Allergic rhinitis, Guideline, Evidence, Surgery, Treatment
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|